RAS and FLT3 (FMS-like tyrosine kinase 3) mutations, in particular, as well as IKZF1 mutation, can be identified as drivers in B-ALL samples with higher frequency. Here, FLT3 is linked to precursor B-cell acute lymphoblastic leukemia.